Camrelizumab for the treatment of advanced cervical adenocarcinoma: a case report and literature review

Cervical adenocarcinoma belongs to an invasive subtype of cervical carcinoma, presenting poorly prognostic status. Chemotherapy treatment for recurrent cervical carcinoma are thought to be limited and supposed to be noncurative. Because of the poor prognosis of patients with recurrent cervical carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Jiang, Yuqi, Xue, Chaofan, Chen, Huiyong, Zhang, Yongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908119/
https://www.ncbi.nlm.nih.gov/pubmed/35280424
http://dx.doi.org/10.21037/atm-22-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908119/
https://www.ncbi.nlm.nih.gov/pubmed/35280424
http://dx.doi.org/10.21037/atm-22-67

Ejemplares similares